SHS Gesellschaft für Beteiligungsmanagement mbH

Newsletter Current page: 8

5. August 2021 - Newsletter, Portfolio News

c-LEcta, one of the leading enzyme specialists, for the first time with 10 million euros turnover per year

The company c-LEcta is one of the world’s leading biotech companies in the field of enzyme production. More than 200 customers in 40 countries, including well-known pharmaceutical companies, rely on the enzyme products from Leipzig. 2020 was a successful year for c-LEcta, in which the 10 million euro mark in turnover was broken for the […]

Read more
5. August 2021 - Newsletter, Portfolio News

Experienced and well-connected: Dr Alan Levy becomes Chairman of the Board of Salvia BioElectronics

With the appointment of Dr. Alan Levy as Chairman of the Board, the Dutch growth company Salvia BioElectronics brings profound life science expertise and decades of experience to the team. Dr Levy has successfully exited four out of five early-stage healthcare companies and also sits on the board of Intuitive Surgical. Salvia develops electromedical neurostimulation […]

Read more
22. July 2021 - Newsletter, Press Releases

ESG investing in the focus of institutional investors

An interview with Dr Hanno Kühn, Chief Investment Officer (CIO) and head of apoBank’s institutional investment business, and Hubertus Leonhardt, Managing Director and partner of SHS Gesellschaft für Beteiligungsmanagement mbH. As the largest cooperative primary bank in Germany, apoBank is the number one financial services provider in the health care sector. Its business activities include […]

Read more
29. April 2021 - Newsletter, Portfolio News

On course for growth despite pandemic: Tyromotion, leading manufacturer of technology-based rehabilitation equipment

Despite the Corona pandemic, the high-tech company Tyromotion GmbH reports considerable success. Tyromotion develops state-of-the-art rehabilitation devices, among others for MS patients and stroke patients. Thanks to state-of-the-art robotics, sensor technology and virtual reality, the rehabilitation process becomes more intensive and the patient sees successes more quickly. The concept also convinced customers in Australia, where […]

Read more
29. April 2021 - Newsletter, Portfolio News

Danish specialist clinic for epilepsy relies on AI-based diagnostic system from Neuro Event Labs

Neuro Event Labs Oy is a leading healthtech company in the field of AI-based diagnosis and monitoring of epilepsy patients. Now the SHS portfolio company announces an extensive cooperation with Filadelfia Epilepsy Hospital in Dianalund. The renowned specialist clinic for epilepsy patients in western Denmark will use the AI-based diagnostic tool Nelli Pro on all […]

Read more
29. April 2021 - Newsletter, Portfolio News

New CEO at active ingredient specialist AMW to drive international expansion

The successful specialty pharmaceutical company AMW GmbH is expanding its management team and bringing experience and leadership to its new CEO, Dr. Konstantin Petropoulus. With his many years of expertise, the molecular biologist with an MBA is to help strengthen AMW’s global presence. In addition, Dr. Petropoulus will expand the drug delivery system pipeline with […]

Read more
29. April 2021 - Newsletter, Portfolio News

c-LEcta receives EXCiPACT certification: accolade for high quality standard

With the internationally recognised EXCiPACT certification, the globally successful biotech company c-LEcta GmbH from Leipzig receives confirmation of its high quality standards in production and distribution (GMP and GDP). The certificate is recognised worldwide by relevant authorities such as the European Union (EU), the US Food and Drug Administration (FDA) and the UK Medicines and […]

Read more
29. April 2021 - Newsletter, Portfolio News

Successful exit: SHS sells stake in CryLaS, a specialist in laser technology for the healthcare, biotech and semiconductor industries

With pulsed and CW laser systems in the deep UV range, Crystal Laser Systems GmbH enjoys a very good reputation worldwide in the healthcare, biotech and semiconductor sectors. SHS is selling the profitable and rapidly growing company to the investor SIP, which intends to further strengthen the market position of CryLaS with new products and […]

Read more
First Previous
...
67
8
910
...
Next Last